Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05875857 · ClinicalTrials.gov registry record · NA
Patient Utilization of Opioid Destruction Bags in the Post-op Period
A NA study of Opioid Use and Total Hip Arthroplasty, sponsored by University of Nebraska.
- Active
- Registry status
- NA
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT05875857: Active NA study of Opioid Use and Total Hip Arthroplasty, sponsored by University of Nebraska.
NCT05875857 is a NA study of Opioid Use and Total Hip Arthroplasty that is active but no longer recruiting, run by University of Nebraska. The registered enrollment target is 163 participants, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05875857, a NA study of Opioid Use and Total Hip Arthroplasty, is active but no longer recruiting, sponsored by University of Nebraska.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medication used, stored disposed of.
Primary Outcome
Number of patients who report they did or plan to destroy unused opioids
Conditions Studied
Interventions
- BEHAVIORAL Opioid destruction education
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2027-01 |
| Phase | NA |
What the registry record for NCT05875857 still lists
NCT05875857 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Opioid destruction education is the first listed.
NCT05875857 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT05875857 about?
NCT05875857 is a clinical study titled "Patient Utilization of Opioid Destruction Bags in the Post-op Period". This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medica...
What is the current status of trial NCT05875857?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 163 participants. The study started on 2023-06-19. Estimated completion is 2027-01.
What conditions does trial NCT05875857 study?
This clinical trial studies the following conditions: Opioid Use, Total Hip Arthroplasty, Opioid Use, Unspecified, Patient Empowerment, Total Knee Arthoplasty.
What interventions are being tested in trial NCT05875857?
The interventions under investigation include: Opioid destruction education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05875857?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05875857 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05875857's enrollment target sits among peer trials
163 45th of 105 higher than 61 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI